Your email has been successfully added to our mailing list.

×
0.0629032258064516 0.0629032258064516 0.0596935483870968 0.0629032258064517 0.0290322580645161 0.0387096774193549 0.00967741935483879 0.00806451612903223
Stock impact report

Could CohBar Inc. Hold The Key To Treating Age-Related Disease? [Seeking Alpha]

CohBar, Inc. (CWBR) 
NASDAQ:AMEX Investor Relations: ir.cohbar.com
Company Research Source: Seeking Alpha
Could CohBar Inc. Hold The Key To Treating Age-Related Disease?SummaryCohBar Inc. is the first company exploring the field of mitochondrial derived peptides as a treatment to age related disease.Their extensive intellectual property portfolio allows them to dominate this field of care, and will attract partnership and licensing deals.Financing will run out in late 2018, but the company hopes to partner with another firm for the MDP treatment for NASH, a field with a large unmet medical need. Show less Read more
Impact Snapshot
Event Time:
CWBR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CWBR alerts
Opt-in for
CWBR alerts

from News Quantified
Opt-in for
CWBR alerts

from News Quantified